Early-stage
HTGF backs €7m seed round for Zimmer Biotech
Zimmer Biotech will focus on developing a skin cancer drug based on 5-Aminolevulinic acid
Bray Capital leads funding round for Glint
Funding will be used to complete development of Glintтs currency and app-based technology
HTGF and MBG back €720,000 seed round for Stimos
HTGF says the technology addresses a problem affecting patients and the health economy
1st Capital Partner leads series-A extension for Hemovent
Original funding round of $6m in February 2016 was provided by a consortium led by MIG Verwaltungs
Debeka and VC firms in €20m round for Ottonova
Holtzbrinck, Vorwerk, Tengelmann and B-to-V reinvested in the round to the tune of €10m
Innogest, Invitalia in €8.4m series-A for GreenBone Ortho
Luxembourg-based investment holding Helsinn Group led the funding round with a €2m injection
Speedinvest in €2.5m round for Fincompare
Business angels and family offices from the banking and finance sectors also invest in the round
Grazia Equity leads $4.9m seed round for Yeay
VC firm Mountain Partners also invested in the round along with well known business angels
Speedinvest leads €1m round for Timeular
Company will use the new money to expand its operations to the US and other international markets
VC-backed Bicycle Therapeutics raises £40m series-B
Round is led by new backer Vertex Ventures and includes several existing investors
Merck leads CHF 10.5m series-A for Inthera Bioscience
Aglaia Biomedical Ventures and Novo Seeds also participated in the round alongside an unnamed private investor
Balderton leads $22m funding round for Frontier Car
EchoVC+, TPG/Satya, NEA and Partech Ventures also took part in the funding round
Ysios, Omega lead €15m series-A for Anaconda Biomed
Additional backers include Banco Sabadell and existing investor Innogest Capital
M Capital, Normandie Participations lead €4.7m Robocath round
Backers are joined in the round by previous investors Go Capital and NCI Gestion
LSP leads €15m series-A for Cardior Pharmaceuticals
New funding will allow the company to develop its lead compound, which targets RNAs linked to heart failure
HTGF et al. invest in Numaferm
European Investment Fund and angel investors also participated in the seed funding round
Target and HTGF in $2.6m Simplaex series-A
Deal is the first of the year for Target and the 15th for High-Tech Gründerfonds
HTGF in €1.5m seed round for Replex
Fresh capital will be used to expand into the US market, with a new office recently opened in San Francisco
Tesi and Debiopharm in $10m series-B for BC Platforms
Biopharmaceutical company will launch new technologies and integrate clinical and genomic data
Novartis, Columbus et al. in €37.5m series-A round for Vivet
Other investors in the round include Roche Venture Fund, HealthCap, Kurma Partners and Ysios Capital
BIVF at al. lead €20m series-A for ImCheck Therapeutics
Backers include Kurma Partners, Idinvest, Gimv and Life Sciences Partners
OxfordCapital and Episode 1 lead $3.1m round for Attest
Market research platform will use the funding to launch its product, and invest in product development
B&M Gates and VCs hold $45.5m series-D for Arsanis
New funding will be used to focus efforts on a phase II study for the prevention of pneumonia
Picus Capital and IBB in €2m seed round for Getsurance
New funding will be used to bring the company's digital disability insurance product to market